These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26649808)

  • 1. Caged [(18)F]FDG Glycosylamines for Imaging Acidic Tumor Microenvironments Using Positron Emission Tomography.
    Flavell RR; Truillet C; Regan MK; Ganguly T; Blecha JE; Kurhanewicz J; VanBrocklin HF; Keshari KR; Chang CJ; Evans MJ; Wilson DM
    Bioconjug Chem; 2016 Jan; 27(1):170-8. PubMed ID: 26649808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic activation of tumor hypoxia: a means to increase tumor 2-deoxy-2-[18F]fluoro-D-glucose uptake?
    Mees G; Dierckx R; Vangestel C; Laukens D; Van Damme N; Van de Wiele C
    Mol Imaging; 2013; 12(1):49-58. PubMed ID: 23348791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of an N-[
    Wu Z; Ma J; Brownell AL; Wang H; Li C; Meng X; Yuan L; Liu H; Li S; Xie J
    Nucl Med Biol; 2018 Nov; 66():40-48. PubMed ID: 30248568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo imaging of therapy response to a novel pan-HER antibody mixture using FDG and FLT positron emission tomography.
    Nielsen CH; Jensen MM; Kristensen LK; Dahlman A; Fröhlich C; Jacobsen HJ; Poulsen TT; Lantto J; Horak ID; Kragh M; Kjaer A
    Oncotarget; 2015 Nov; 6(35):37486-99. PubMed ID: 26460961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
    Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
    Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (18)F-Fluorodeoxyglucamines: Reductive amination of hydrophilic (18)F-fluoro-2-deoxyglucose with lipophilic amines for the development of potential PET imaging agents.
    Baranwal A; Mukherjee J
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2902-6. PubMed ID: 26048782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and evaluation of positron emission tomography/fluorescence dual imaging probes for targeting facilitated glucose transporter 1 (GLUT1).
    Yuen R; Wagner M; Richter S; Dufour J; Wuest M; West FG; Wuest F
    Org Biomol Chem; 2021 Apr; 19(14):3241-3254. PubMed ID: 33885579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of ¹⁸F-labeled fluoropropyl tryptophan analogs as potential PET probes for tumor imaging.
    Chiotellis A; Mu L; Müller A; Selivanova SV; Keller C; Schibli R; Krämer SD; Ametamey SM
    Eur J Med Chem; 2013; 70():768-80. PubMed ID: 24239624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of [(18)F]F-GAZ, a novel oxygen-mimetic azomycin-glucose conjugate, for imaging hypoxic tumor.
    Wuest M; Kumar P; Wang M; Yang J; Jans HS; Wiebe LI
    Cancer Biother Radiopharm; 2012 Oct; 27(8):473-80. PubMed ID: 22746267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice.
    McLarty K; Moran MD; Scollard DA; Chan C; Sabha N; Mukherjee J; Guha A; McLaurin J; Nitz M; Houle S; Wilson AA; Reilly RM; Vasdev N
    Nucl Med Biol; 2011 Oct; 38(7):953-9. PubMed ID: 21982567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: a pilot study.
    Zhang G; Li J; Wang X; Ma Y; Yin X; Wang F; Zheng H; Duan X; Postel GC; Li XF
    J Nucl Med; 2015 Apr; 56(4):607-12. PubMed ID: 25722447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography.
    Schottelius M; Poethko T; Herz M; Reubi JC; Kessler H; Schwaiger M; Wester HJ
    Clin Cancer Res; 2004 Jun; 10(11):3593-606. PubMed ID: 15173065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel synthesis and initial preclinical evaluation of (18)F-[FDG] labeled rhodamine: a potential PET myocardial perfusion imaging agent.
    AlJammaz I; Al-Otaibi B; AlHindas H; Okarvi SM
    Nucl Med Biol; 2015 Oct; 42(10):804-8. PubMed ID: 26160144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
    Cheng Z; Wei R; Wu C; Qing H; Jiang X; Lu H; Chen S; Li X; Xu G; Ai H
    Nucl Med Commun; 2015 Sep; 36(9):914-21. PubMed ID: 25973694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method for direct site-specific radiolabeling of peptides using [18F]FDG.
    Namavari M; Cheng Z; Zhang R; De A; Levi J; Hoerner JK; Yaghoubi SS; Syud FA; Gambhir SS
    Bioconjug Chem; 2009 Mar; 20(3):432-6. PubMed ID: 19226160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.
    Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO
    Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging proliferation in human leukemia-tumor bearing mice with (18)F-FLT: Comparison with (18)F-FDG PET.
    Lu L; Jiang L; Guan H; Gao Y; Lu H
    Hell J Nucl Med; 2012; 15(3):206-9. PubMed ID: 23106052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental study on the therapeutic effect of positron emission tomography agent [¹⁸F]-labeled 2-deoxy-2-fluoro-d-glucose in a colon cancer mouse model.
    Fang S; Wang J; Jiang H; Zhang Y; Xi W; Zhao C; Tian M; Zhang H
    Cancer Biother Radiopharm; 2010 Dec; 25(6):733-40. PubMed ID: 21204768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy response monitoring of the early effects of a new BRAF inhibitor on melanoma xenograft in mice: evaluation of (18) F-FDG-PET and (18) F-FLT-PET.
    Geven EJ; Evers S; Nayak TK; Bergström M; Su F; Gerrits D; Franssen GM; Boerman OC
    Contrast Media Mol Imaging; 2015; 10(3):203-10. PubMed ID: 25204436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.